Etidronate Disodium Tablets
BRIEFING
Etidronate Disodium Tablets. This proposal is based on the version of the monograph official as of May 1, 2020. It is proposed to omit this monograph for the following reasons:
-
No drug products formulated as defined under Etidronate Disodium Tablets are currently marketed in the United States.
-
The drug product is currently not on the list for approved veterinary medicine in the United States.
(SM3: N. Myers)
Correspondence Number—C326116
USP REFERENCE STANDARDS FOR PURCHASE
USP Etidronate Disodium RSUSP Etidronate Disodium Related Compound A RS
USP Etidronic Acid Monohydrate RS